12 Results for "

human DNA polymerase β

" in MedChemExpress (MCE) Product Catalog:
Products (12)

12 Results for "human DNA polymerase β" in MCE Product Catalog:

Cat. No.: HY-137697D
Purity:  ≥98.0%
ddCTP trilithium solution (100 mM) is a chain-terminating dideoxynucleotide. ddCTP trilithium is a type of chain-terminating deoxynucleotide. ddCTP trilithium can be incorporated into the extension primer chain that lacks the 3'-hydroxyl group, thereby terminating primer extension, viral genome replication, and DNA synthesis. ddCTP trilithium can distinguish almost identical RNA through distinguishable extension products in primer extension inhibition experiments. ddCTP trilithium is the active metabolite of Zalcitabine (HY-17392), which can competitively inhibit HIV reverse transcriptase, terminate the synthesis of viral DNA chains, and thereby inhibit HIV replication .
loading...
    loading...
Cat. No.: HY-50735
CAS No.: 69123-90-6
Synonyms: NSC 382097; FIAC; FOAC
Target:  

HSV EBV DNA/RNA Synthesis

Research Areas:  

Infection

Fiacitabine (NSC 382097; FIAC; FOAC) is a potent and highly selective anti-herpesvirus agent. Fiacitabine acts as an inhibitor of HSV DNA polymerase, with a Ki of 0.26 μM for HSV-1 and 0.42 μM for HSV-2, respectively. Fiacitabine can be efficiently phosphorylated by thymidine kinase encoded by the virus itself to generate FIACTP, an active triphosphate metabolite. Fiacitabine is applicable to research related to herpesvirus infections .
loading...
    loading...
Cat. No.: HY-137697
CAS No.: 66004-77-1
ddCTP is a type of chain-terminating deoxynucleotide. ddCTP can be incorporated into the extension primer chain that lacks the 3'-hydroxyl group, thereby terminating primer extension, viral genome replication, and DNA synthesis. ddCTP can distinguish almost identical RNA through distinguishable extension products in primer extension inhibition experiments. ddCTP is the active metabolite of Zalcitabine (HY-17392), which can competitively inhibit HIV reverse transcriptase, terminate the synthesis of viral DNA chains, and thereby inhibit HIV replication .
loading...
    loading...
Cat. No.: HY-N9454
CAS No.: 91893-83-3
Garcinoic acid is an orally active anti-inflammatory agent that crosses the blood-brain barrier. Garcinoic acid also enhances efferocytosis and enzyme/receptor regulation, and selectively inhibits human COX-2, porcine α-amylase, Saccharomyces cerevisiae α-glucosidase and human DNA polymerase β (IC50=11 μM), as well as activates human PXR. Garcinoic acid enhances macrophage efferocytosis via receptors such as MerTK and LRP-1, and promotes the production of pro-resolving lipid mediators. Garcinoic acid inhibits NF-κB activation and pro-inflammatory cytokine secretion, interferes with Aβ aggregation, downregulates NLRP3 inflammasome activity, and binds to targets including CD44 and EGFR to inhibit leukemia cell proliferation. The pharmacological activities of Garcinoic acid, such as antioxidant, anti-inflammatory and lipid metabolism-regulating effects, are widely used in studies related to various diseases including atherosclerosis, Alzheimer's disease, type 2 diabetes, inflammatory bowel disease and viral pneumonia .
loading...
    loading...
Cat. No.: HY-120105
CAS No.: 170747-33-8
NSC666715 is a DNA polymerase β (Pol-β) inhibitor. NSC666715 directly and specifically interacts with Pol-β, interferes with its binding to damaged DNA, blocks its dRP lyase activity, and inhibits Pol-β-mediated SN- and LP-BER. NSC666715 induces AP site accumulation and S-phase cell cycle arrest, and triggers senescence and apoptosis (apoptosis) via the p53/p21 pathway in colorectal cancer cells. NSC666715 enhances TMZ (HY-17364)-induced DNA damage, senescence and apoptosis, and potentiates the cytotoxicity of TMZ. NSC666715 inhibits tumor growth in colon cancer xenograft models. NSC666715 can be used in research related to colorectal cancer .
loading...
    loading...
Cat. No.: HY-137697B
CAS No.: 93939-77-6
ddCTP trilithium is a type of chain-terminating deoxynucleotide. ddCTP trilithium can be incorporated into the extension primer chain that lacks the 3'-hydroxyl group, thereby terminating primer extension, viral genome replication, and DNA synthesis. ddCTP trilithium can distinguish almost identical RNA through distinguishable extension products in primer extension inhibition experiments. ddCTP trilithium is the active metabolite of Zalcitabine (HY-17392), which can competitively inhibit HIV reverse transcriptase, terminate the synthesis of viral DNA chains, and thereby inhibit HIV replication .
loading...
    loading...
Cat. No.: HY-19869
CAS No.: 878670-89-4
Research Areas:  

Infection

VRX-480773 is an efficient non-nucleoside reverse transcriptase inhibitor (NNRTI), used for HIV infection. VRX-480773 has high specificity for HIV-1, with an EC50 for wild-type HIV-1 being 0.14 nM. VRX-480773 does not inhibit HIV-2, HBV or HCV, and has no effect on human DNA polymerase α/β. VRX-480773 retains inhibitory activity against Efavirenz (HY-10572) resistant strains, with EC50s mostly < 1 nM. VRX-480773 can be used for research on AIDS .
loading...
    loading...
Cat. No.: HY-P7883
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: POLB; 5'-DRP Lyase; DNA polymerase Beta; AP Lyase; polymerase (DNA Directed), Beta; DNA polymerase Beta Subunit; 5'-Deoxyribose-Phosphate Lyase; DNA polymerase; polymerase (DNA) Beta; DNA Pol Beta
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-182552
CAS No.: 65025-62-9
Soulattrolide is a non-nucleoside HIV-1 reverse transcriptase (RT) inhibitor with IC50 values of 0.34 µM for HIV-1 RT, 69.5 µM for E. coli RNase H, and >495 µM for human DNA polymerase β, and can be found in Calophyllum teysmannii latex. Soulattrolide can be used for the research of HIV-1 infection, pain, inflammation, and Mycobacterium tuberculosis infection .
loading...
    loading...
Cat. No.: HY-186293
CAS No.: 662144-62-9
Research Areas:  

Cancer

3-Lauroylcatechin is a DPPH free radical scavenger. 3-Lauroylcatechin inhibits the activities of mammalian DNA polymerase α and β. 3-Lauroylcatechin can be used in studies related to colon cancer .
loading...
    loading...
Cat. No.: HY-N21920
CAS No.: 796062-77-6
Dehydrotrametenonic acid is a DNA topoisomerase II (DNA topoisomerase II) inhibitor with an IC50 of 37.5 μM. Dehydrotrametenonic acid inhibits DNA polymerase α and β, with IC50 values of 45.5 μM and 86.5 μM, respectively. Dehydrotrametenonic acid does not intercalate into DNA and exhibits a topoisomerase II inhibitory mechanism similar to that of an inhibitor. Dehydrotrametenonic acid suppresses the growth of NUGC-3 gastric cancer cells with an LD50 of 63.6 μM, and inhibits TPA-induced EBV-EA activation in Raji cells. Dehydrotrametenonic acid can be used in studies related to DNA replication, cell cycle and cancer .
loading...
    loading...
Cat. No.: HY-N21925
CAS No.: 18449-25-7
Dehydroeburiconic acid is a DNA polymerase α/β inhibitor, with IC50 values of 40.8 μM and 30.0 μM against calf DNA polymerase α and rat DNA polymerase β, respectively. Dehydroeburiconic acid can be used in studies related to lanostane-type triterpenoids and DNA polymerase .
loading...
    loading...
  • 1